Sumitomo Pharma Hits Day High with 7.54% Surge in Stock Price

Sumitomo Pharma Co., Ltd. has experienced a significant uptick in its stock performance, gaining 7.54% on April 1, 2026. The stock reached an intraday high of JPY 2,232.00, reflecting strong market activity. Over the past week, Sumitomo Pharma has outperformed the Japan Nikkei 225, with a weekly gain of 12.02% compared to a slight decline of 0.02% in the index. In terms of annual performance, Sumitomo Pharma has delivered an impressive return of 213.04%, significantly surpassing the Nikkei 225's 50.85% return. The company's financial metrics indicate robust growth, with a net profit of JPY 96,471 million and a return on capital employed (ROCE) of 48.39%. Additionally, the company reported a notable increase in net sales of 1.26% and has maintained a strong operating cash flow of JPY 53,277 million. With a market capitalization of JPY 1,094,225 million, Sumitomo Pharma continues to demonstrate its position as a key player in the pharmaceuticals and biotechnology industry, showcasing resilience and strong financial health amidst market fluctuations.